Open AccessImaging in Lymphoma: The Key Role of Fluorodeoxyglucose‐Positron Emission Tomography
Author(s) -
Meignan Michel,
Hutchings Martin,
Schwartz Lawrence H.
Publication year - 2015
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2015-0036
Subject(s) - medicine , positron emission tomography , fluorodeoxyglucose , lymphoma , medical physics , nuclear medicine , positron emission , positron emission tomography computed tomography , preclinical imaging , radiology , brain positron emission tomography , clinical practice , pathology , family medicine , microbiology and biotechnology , biology , in vivo
This review focuses on the impact of new imaging guidelines for fluorodeoxyglucose‐positron emission tomography (FDG‐PET) on clinical practice and the future directions of lymphoma imaging.